| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on April 17, 2003
Accepted on November 26, 2003
1 Center for Cell Signaling, Department of Biochemistry and Molecular Genetics, Cell and Molecular Biology Program, and Department of Microbiology, Department of Health Evaluation Sciences; University of Virginia, Charlottesville, VA 22908
* To whom correspondence should be addressed. E-mail: paschal{at}virginia.edu.
Here we report that mutations within the DNA-binding domain of AR, shown previously to inhibit nuclear export to the cytoplasm, cause an androgen-dependent defect in intra-nuclear trafficking of AR. Mutation of two conserved phenylalanines within the DNA recognition helix (F582,583A) results in androgen-dependent arrest of AR in multiple sub-nuclear foci. A point mutation in one of the conserved phenylalanines (
F582,F582Y) is known to cause Androgen Insensitivity Syndrome (AIS). Both AIS mutants (
F582,F582Y) and the export mutant (F582,583A) displayed androgen-dependent arrest in foci, and all three mutants promoted androgen-dependent accumulation of the histone acetyl transferase CBP in the foci. The foci correspond to a sub-nuclear compartment that is highly enriched for the steroid receptor co-activator GRIP-1. Agonist-bound WT AR induces the redistribution of GRIP-1 from foci to the nucleoplasm. This likely reflects a direct interaction between these proteins because mutation of a conserved residue within the major co-activator binding site on AR (K720A) inhibits AR-dependent dissociation of GRIP-1 from foci. GRIP-1 also remains foci-associated in the presence of agonist-bound F582,583A,
F582, or F582Y forms of AR. Two-dimensional phospho-peptide mapping and analysis with a phospho-specific antibody revealed that mutant forms of AR that arrest in the sub-nuclear foci are hypo-phosphorylated at Ser81, a site that normally undergoes androgen-dependent phosphorylation. Our working model is that the sub-nuclear foci are sites where AR undergoes ligand-dependent engagement with GRIP-1 and CBP, a recruitment step that occurs before Ser81 phosphorylation and association with promoters of target genes.
NURSA Molecule Pages Link:
This article has been cited by other articles:
![]() |
G. N. Corry, M. J. Hendzel, and D. A. Underhill Subnuclear localization and mobility are key indicators of PAX3 dysfunction in Waardenburg syndrome Hum. Mol. Genet., June 15, 2008; 17(12): 1825 - 1837. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Nakauchi, K.-i. Matsuda, I. Ochiai, A. Kawauchi, Y. Mizutani, T. Miki, and M. Kawata A Differential Ligand-mediated Response of Green Fluorescent Protein-tagged Androgen Receptor in Living Prostate Cancer and Non-prostate Cancer Cell Lines J. Histochem. Cytochem., June 1, 2007; 55(6): 535 - 544. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Lin, P. Philibert, B. Ferraz-de-Souza, D. Kelberman, T. Homfray, A. Albanese, V. Molini, N. J. Sebire, S. Einaudi, G. S. Conway, et al. Heterozygous Missense Mutations in Steroidogenic Factor 1 (SF1/Ad4BP, NR5A1) Are Associated with 46,XY Disorders of Sex Development with Normal Adrenal Function J. Clin. Endocrinol. Metab., March 1, 2007; 92(3): 991 - 999. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Chen, Y. Xu, X. Yuan, G. J. Bubley, and S. P. Balk Androgen receptor phosphorylation and stabilization in prostate cancer by cyclin-dependent kinase 1 PNAS, October 24, 2006; 103(43): 15969 - 15974. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Georget, W. Bourguet, S. Lumbroso, S. Makni, C. Sultan, and J.-C. Nicolas Glutamic Acid 709 Substitutions Highlight the Importance of the Interaction between Androgen Receptor Helices H3 and H12 for Androgen and Antiandrogen Actions Mol. Endocrinol., April 1, 2006; 20(4): 724 - 734. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Grenier, A. Trousson, A. Chauchereau, J. Cartaud, M. Schumacher, and C. Massaad Differential Recruitment of p160 Coactivators by Glucocorticoid Receptor between Schwann Cells and Astrocytes Mol. Endocrinol., February 1, 2006; 20(2): 254 - 267. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Taneja, S. Ha, N. K. Swenson, H. Y. Huang, P. Lee, J. Melamed, E. Shapiro, M. J. Garabedian, and S. K. Logan Cell-specific Regulation of Androgen Receptor Phosphorylation in Vivo J. Biol. Chem., December 9, 2005; 280(49): 40916 - 40924. [Abstract] [Full Text] [PDF] |
||||
![]() |
M-B Debril, L Dubuquoy, J-N Feige, W Wahli, B Desvergne, J Auwerx, and L Gelman Scaffold attachment factor B1 directly interacts with nuclear receptors in living cells and represses transcriptional activity J. Mol. Endocrinol., December 1, 2005; 35(3): 503 - 517. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-S. Yang, M. J. Vitto, S. A. Busby, B. A. Garcia, C. T. Kesler, D. Gioeli, J. Shabanowitz, D. F. Hunt, K. Rundell, D. L. Brautigan, et al. Simian Virus 40 Small t Antigen Mediates Conformation-Dependent Transfer of Protein Phosphatase 2A onto the Androgen Receptor Mol. Cell. Biol., February 15, 2005; 25(4): 1298 - 1308. [Abstract] [Full Text] [PDF] |
||||
![]() |
J Kim, L Jia, M R Stallcup, and G A Coetzee The role of protein kinase A pathway and cAMP responsive element-binding protein in androgen receptor-mediated transcription at the prostate-specific antigen locus J. Mol. Endocrinol., February 1, 2005; 34(1): 107 - 118. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hoang, I. S. Fenne, C. Cook, B. Borud, M. Bakke, E. A. Lien, and G. Mellgren cAMP-dependent Protein Kinase Regulates Ubiquitin-Proteasome-mediated Degradation and Subcellular Localization of the Nuclear Receptor Coactivator GRIP1 J. Biol. Chem., November 19, 2004; 279(47): 49120 - 49130. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |